Summary:
This research study is for an inhaled insulin product given to patients with Type 2 Diabetes and who are also diagnosed with either COPD or Asthma.
Qualified Participants Must:
• Have been diagnosed with either Type 1 or Type 2 Diabetes
•
Have been diagnosed with either Asthma or COPD
•
Have never smoked or are a former smoker (stopped 6 months prior to their first study visit)
Qualified Participants May Receive:
Compensation may be available for time and travel.